Canada ranks third globally for new clinical trials, but threats to that standing are gathering steam.
Healthcare infrastructure is no longer limited to bricks and mortar. Digital technologies and infrastructure have become just as essential to delivering high-quality care.
The federal Biomanufacturing and Life Sciences Strategy, released in 2021, did not result in needed policy changes or alignment of federal departments and investments. In contrast, other top-tier countries place life sciences at the centre of industrial strategies and align the sector with talent, trade, research and development, innovation and infrastructure.
If we put health at the centre of Canada’s AI strategy, we can strengthen our healthcare system while lowering costs, improving patient care, boosting productivity, accelerating life-changing health discoveries, and growing a globally competitive industry that pays dividends for decades.